US Stock MarketDetailed Quotes

KALA KALA BIO

Watchlist
  • 7.0074
  • +0.2525+3.74%
Close May 3 16:00 ET
  • 6.8200
  • -0.1874-2.67%
Post 18:34 ET
19.74MMarket Cap-403P/E (TTM)

About KALA BIO Company

KALA BIO, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.

Company Profile

SymbolKALA
Company NameKALA BIO
Listing DateJul 20, 2017
Issue Price15.00
Founded2009
CEOMr. Mark T. Iwicki
MarketNASDAQ
Employees43
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1167 Massachusetts Avenue
CityArlington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02476
Phone1-781-996-5252
Websitehttp://www.kalarx.com

Company Executives

  • Name
  • Position
  • Salary
  • Mark T. Iwicki
  • Chairman of the Board and Chief Executive Officer
  • 1.87M
  • Todd Bazemore
  • Chief Operating Officer and President
  • 1.03M
  • Eric L. Trachtenberg
  • General Counsel, Chief Compliance Officer and Corporate Secretary
  • --
  • Dr. R. Kim Brazzell,PhD
  • Head of Research and Development and Chief Medical Officer
  • 993.69K
  • Mary Reumuth
  • Chief Financial Officer, Treasurer and Principal Accounting Officer
  • --
  • Darius Kharabi
  • Chief Business Officer
  • --
  • Mark S. Blumenkranz, M.D.
  • Independent Director
  • 66.24K
  • Howard B. Rosen
  • Independent Director
  • 77.65K
  • Dr. Marjan Farid, M.D.
  • Independent Director
  • 16.79K
  • Gregory D. Perry
  • Independent Director
  • 80.15K
  • C. Daniel Myers
  • Independent Director
  • 72.65K
  • Andrew I. Koven
  • Lead Independent Director
  • 101.44K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg